查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1401981

2030 年胜肽合成市场预测：按产品、技术、应用、最终用户和地区进行的全球分析

Peptide Synthesis Market Forecasts to 2030 - Global Analysis By Product (Equipment, Reagents, Consumables and Other Products), Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC预测，2023年全球胜肽合成市场规模将达51亿美元，预计2030年将达到102亿美元，预测期内复合年增长率为10.2%。

形成胜肽（透过胜肽键连接的胺基酸短链）的化学过程称为胜肽合成。胺基酸必须按照预定的顺序阶段组装，反应的控制通常需要保留特定的官能基。合成胜胜肽有多种方法，包括固相合成、溶液相合成和重组DNA技术。

据 ClinicalTrials.gov 称，正在开发 21 种胜肽药物来治疗 COVID-19，其中 15 种用于急性呼吸窘迫症候群(ARDS)，这是一种肺部无法为身体重要器官提供足够氧气的疾病是一种合成胜胜肽，用于治疗SARS-COV-2感染引起的呼吸道疾病。

个体化药物的开发

随着个体化医疗的出现，胜肽合成领域预计将显着成长。个体化医疗的理念是透过根据特定患者情况客製化胜胜肽的能力来实现的。胜肽提供实现个体化治疗计划所需的标靶性、客製性和特异性。随着个人化医疗的不断发展和普及，对胜肽合成技术、服务和产品的需求预计将急剧增加。

有关给药的问题

由于胃肠道吸收较差，大多数治疗性胜肽透过肠胃外途径给药。胜肽药物的口服生物利用度有限，主要是由于全身性酵素的降解。此外，它们的大分子量和带电官能基会抑制吸收。由于这些特性，大多数给药胜肽的生物利用度有限且半衰期短。因此，这对市场来说是一个挑战。

罕见疾病治疗方法的进展

胜肽有可能治疗罕见疾病和不寻常的遗传问题。随着个体化医疗的出现，胜肽合成领域具有巨大的成长潜力。胜肽提供实现个体化治疗计划所需的标靶化、客製性和特异性。随着个人化医疗的不断发展和普及，对胜肽合成技术、服务和产品的需求预计将急剧增加。

精製和品管

为了使研究和治疗应用有效，必须获得高纯度的胜肽。高效液相层析(HPLC) 是一种精製技术，但它可能非常耗时，并且必须针对每个胜肽序列进行最佳化。需要采取品管步骤来确保合成的胜肽准确、一致和安全。对于市场来说，维持有效的精製程序和高品质标准可能很困难。

新冠肺炎 (COVID-19) 影响：

这次疫情扰乱了世界各地的供应线，影响了胜肽合成所需原料和设备的可得性。合成胜胜肽的总分布和可得性受到生产和出货延误的影响。大流行使医疗保健的重点发生了重大转变。对与 COVID-19 研究相关的一些胜肽类药物和疫苗的需求可能增加，而非必要医疗保健服务的中断可能会减少对其他胜肽产品的需求。

预计试剂细分市场在预测期内将是最大的

预计试剂细分市场将成为预测期内最大的细分市场。胜肽合成过程将胺基酸化学结合形成胜肽。透过使用促进更快、更有效胜肽键形成的特定化学物质可以减少合成时间。透过减少副作用和污染物，并使用适当的试剂，您可以获得更高纯度的胜肽。某些试剂具有高度选择性，因此有助于胺基酸的精确偶联，而不会发生不良反应。

製药和生物技术公司领域预计在预测期内复合年增长率最高

製药和生物技术公司领域预计在预测期内复合年增长率最高。胜肽疗法因其低毒性、高效和成本效益而成为更多研究和开发的主题。胜肽合成仪的快速技术进步和强大的胜肽治疗产品线是推动製药和生物技术公司胜肽合成产业的主要因素。

占有率最大的地区

预计北美在预测期内将占据最大的市场占有率。定制疗法生产的扩大、基因组学和蛋白​​质组学领域的深入研究以及对创建基于结构的药物设计的投资增加正在支持该地区的市场。此外，由于人们对易于使用的胜肽合成方法的认识不断提高，预计市场将会扩大。

复合年增长率最高的地区：

预计亚太地区在预测期内将维持最高的复合年增长率。由于主要参与者的投资增加，预计该市场将显着开拓。此外，该地区市场的推动因素包括新型胜肽疗法意识的增强、医疗保健成本的上升、更先进的医疗设施的可用性以及行业主要参与者为创造新的胜肽合成而进行的大量投资技术，预计将随着投资而成长。

免费客製化服务：

订阅此报告的客户将收到以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球胜胜肽合成市场：副产品

  • 装置
    • 胜肽合成仪
    • 层析法设备
    • 冷冻干燥机
  • 试剂
  • 消耗品
  • 其他产品

第六章全球胜胜肽合成市场：依技术分类

  • 液相胜胜肽合成
  • 固相胜胜肽合成
  • 混合和重组技术

第七章全球胜肽合成市场：依应用分类

  • 治疗
    • 代谢紊乱
    • 癌症
    • 呼吸系统疾病
    • 心血管疾病
    • 胃肠道疾病
    • 感染疾病
    • 皮肤科疾病
    • 疼痛管理
    • 中枢神经系统疾病
    • 肾臟疾病
    • 其他治疗
  • 诊断
  • 研究
  • 其他用途

第八章全球胜胜肽合成市场：依最终用户分类

  • 製药和生物技术公司
  • 契约製造组织
  • 学术的
  • 其他最终用户

第九章全球胜肽合成市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司简介

  • Biotage
  • Genscript Biotech
  • Thermo Fisher Scientific
  • Merck KGaA
  • Creative Diagnostics
  • CEM Corporation
  • Bachem Holdings
  • PuroSynth
  • Syngene
  • Lonza
  • Polypeptide Group
  • Novo Nordisk A/S
  • MP Biomedicals
  • Evonik
Product Code: SMRC24501

According to Stratistics MRC, the Global Peptide Synthesis Market is accounted for $5.1 billion in 2023 and is expected to reach $10.2 billion by 2030 growing at a CAGR of 10.2% during the forecast period. The chemical process of forming peptides, which are short chains of amino acids joined by peptide bonds, is known as peptide synthesis. It entails assembling amino acids step-by-step in a predetermined order, and controlling the reaction frequently necessitates the preservation of particular functional groups. There are several ways to synthesize peptides, including solid-phase synthesis, solution-phase synthesis, and recombinant DNA technology.

According to Clinical Trials.gov, 21 peptide drugs were in development for the treatment of COVID-19, including 15 synthetic peptides for acute respiratory distress syndrome (ARDS), a life-threatening condition in which the lungs are unable to provide enough oxygen to the body's vital organs, and other respiratory illnesses caused by SARS-Cov-2 infection.

Market Dynamics:

Driver:

Development of personalized medicines

The peptide synthesis sector has significant growth prospects due to the emergence of customized medicine. The idea of customized medicine is made possible by the ability to customize peptides to fit certain patient profiles. They provide the necessary targeting, customisation, and specificity to enable individualized treatment plans. It is anticipated that the need for peptide synthesis technology, services, and products will increase dramatically as personalized medicine continues to develop and gain popularity.

Restraint:

Problems related to the administrative route

The majority of therapeutic peptides are administered by the parenteral route because of insufficient absorption from the gastrointestinal tract. Peptide medications have a limited oral bioavailability mostly due to pre-systemic enzymatic breakdown. Additionally, the large molecular weight and charged functional groups of these medicines sometimes impede their absorption. These features result in the majority of peptides taken orally having limited bioavailability and brief half-lives. Hence, it can be considered a challenge for the market.

Opportunity:

Advancement in therapeutics for rare diseases

Peptides could be able to cure orphan illnesses and unusual genetic problems. The peptide synthesis sector has significant growth prospects due to the emergence of customized medicine. Peptides provide the necessary targeting, customisation, and specificity to enable individualized treatment plans. It is anticipated that the need for peptide synthesis technology, services, and products will increase dramatically as personalized medicine continues to develop and gain popularity.

Threat:

Purification and quality control

Peptides must be obtained with a high degree of purity in order for research and therapeutic applications to be effective. High-performance liquid chromatography (HPLC) is one of the purification techniques that might take a long time and need to be optimized for every peptide sequence. For synthesized peptides to be accurate, consistent, and safe, quality control procedures are necessary. The market may find it difficult to maintain effective purification procedures and high standards of quality.

COVID-19 Impact:

The pandemic affected the availability of raw materials and equipment required for peptide synthesis by upsetting supply lines around the world. The total distribution and availability of synthesized peptides were impacted by production and shipping delays. The pandemic caused a major shift in the focus of healthcare. Demand for some peptide-based medications or vaccines associated with COVID-19 research may have increased, while interruptions in non-essential healthcare services may have resulted in a decline in demand for other peptide products.

The reagents segment is expected to be the largest during the forecast period

The reagents segment is expected to be the largest during the forecast period. The process of peptide synthesis entails joining amino acids chemically to form peptides. Synthesis times can be shortened by using certain chemicals that promote quicker and more effective peptide bond formation. By reducing side effects and contaminants, using the right reagent can result in a peptide that is more pure. Certain reagents help with the precise coupling of amino acids without producing undesirable reactions since they are very selective.

The pharmaceutical and biotechnology companies segment is expected to have the highest CAGR during the forecast period

The pharmaceutical and biotechnology companies segment is expected to have the highest CAGR during the forecast period. Peptide treatments are the subject of more study and development because they are less toxic, efficacious, and cost-effective. Rapid technical improvements in peptide synthesizers and a robust pipeline of peptide therapies are the main factors driving the peptide synthesis industry in pharmaceutical and biotechnology firms.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. Growth in the production of customized therapies, substantial research in the fields of genomics and proteomics, and greater investments in the creation of structure-based medicine designs have all helped the regional market. Additionally, the market will expand due to the increased awareness of the accessible peptide synthesis methods.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. The market is expected to develop significantly as a result of the increase in investments made by important players. Furthermore, it is expected that the region's market will grow due to rising awareness of novel peptide treatments, rising healthcare costs, the availability of more cutting-edge healthcare facilities, and significant investments made by the major players in the industry to create new peptide synthesis technologies.

Key players in the market:

Some of the key players in Peptide Synthesis market include Biotage, Genscript Biotech, Thermo Fisher Scientific, Merck KGaA, Creative Diagnostics, CEM Corporation, Bachem Holdings, PuroSynth, Syngene, Lonza, Polypeptide Group, Novo Nordisk A/S, MP Biomedicals and Evonik.

Key Developments:

In January 2023, Merck announced an agreement to acquire the peptide synthesis company Asymchem. This acquisition will give Merck access to Asymchem's expertise in peptide synthesis and its global manufacturing network.

In December 2022, Thermo Fisher announced an agreement to acquire the peptide synthesis company Protagen. This acquisition will give Thermo Fisher access to Protagen's expertise in peptide synthesis and its global manufacturing network.

Products Covered:

  • Equipment
  • Reagents
  • Consumables
  • Other Products

Technologies Covered:

  • Solution-Phase Peptide Synthesis
  • Solid-Phase Peptide Synthesis
  • Hybrid & Recombinant Technology

Applications Covered:

  • Therapeutics
  • Diagnosis
  • Research
  • Other Applications

End Users Covered:

  • Pharmaceutical and Biotechnology Companies
  • Contract Manufacturing Organization
  • Academic
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Anaysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Peptide Synthesis Market, By Product

  • 5.1 Introduction
  • 5.2 Equipment
    • 5.2.1 Peptide Synthesizers
    • 5.2.2 Chromatography Equipment
    • 5.2.3 Lyophilizers
  • 5.3 Reagents
  • 5.4 Consumables
  • 5.5 Other Products

6 Global Peptide Synthesis Market, By Technology

  • 6.1 Introduction
  • 6.2 Solution-Phase Peptide Synthesis
  • 6.3 Solid-Phase Peptide Synthesis
  • 6.4 Hybrid & Recombinant Technology

7 Global Peptide Synthesis Market, By Application

  • 7.1 Introduction
  • 7.2 Therapeutics
    • 7.2.1 Metabolic Disorders
    • 7.2.2 Cancer
    • 7.2.3 Respiratory Disorders
    • 7.2.4 Cardiovascular Disorders
    • 7.2.5 Gastrointestinal Disorders
    • 7.2.6 Infectious Diseases
    • 7.2.7 Dermatology Disorders
    • 7.2.8 Pain Management
    • 7.2.9 CNS Disorders
    • 7.2.10 Renal Disorders
    • 7.2.11 Other Therapeutics
  • 7.3 Diagnosis
  • 7.4 Research
  • 7.5 Other Applications

8 Global Peptide Synthesis Market, By End User

  • 8.1 Introduction
  • 8.2 Pharmaceutical and Biotechnology Companies
  • 8.3 Contract Manufacturing Organization
  • 8.4 Academic
  • 8.5 Other End Users

9 Global Peptide Synthesis Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Biotage
  • 11.2 Genscript Biotech
  • 11.3 Thermo Fisher Scientific
  • 11.4 Merck KGaA
  • 11.5 Creative Diagnostics
  • 11.6 CEM Corporation
  • 11.7 Bachem Holdings
  • 11.8 PuroSynth
  • 11.9 Syngene
  • 11.10 Lonza
  • 11.11 Polypeptide Group
  • 11.12 Novo Nordisk A/S
  • 11.13 MP Biomedicals
  • 11.14 Evonik

List of Tables

  • Table 1 Global Peptide Synthesis Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Peptide Synthesis Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Peptide Synthesis Market Outlook, By Equipment (2021-2030) ($MN)
  • Table 4 Global Peptide Synthesis Market Outlook, By Peptide Synthesizers (2021-2030) ($MN)
  • Table 5 Global Peptide Synthesis Market Outlook, By Chromatography Equipment (2021-2030) ($MN)
  • Table 6 Global Peptide Synthesis Market Outlook, By Lyophilizers (2021-2030) ($MN)
  • Table 7 Global Peptide Synthesis Market Outlook, By Reagents (2021-2030) ($MN)
  • Table 8 Global Peptide Synthesis Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 9 Global Peptide Synthesis Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 10 Global Peptide Synthesis Market Outlook, By Technology (2021-2030) ($MN)
  • Table 11 Global Peptide Synthesis Market Outlook, By Solution-Phase Peptide Synthesis (2021-2030) ($MN)
  • Table 12 Global Peptide Synthesis Market Outlook, By Solid-Phase Peptide Synthesis (2021-2030) ($MN)
  • Table 13 Global Peptide Synthesis Market Outlook, By Hybrid & Recombinant Technology (2021-2030) ($MN)
  • Table 14 Global Peptide Synthesis Market Outlook, By Application (2021-2030) ($MN)
  • Table 15 Global Peptide Synthesis Market Outlook, By Therapeutics (2021-2030) ($MN)
  • Table 16 Global Peptide Synthesis Market Outlook, By Metabolic Disorders (2021-2030) ($MN)
  • Table 17 Global Peptide Synthesis Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 18 Global Peptide Synthesis Market Outlook, By Respiratory Disorders (2021-2030) ($MN)
  • Table 19 Global Peptide Synthesis Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
  • Table 20 Global Peptide Synthesis Market Outlook, By Gastrointestinal Disorders (2021-2030) ($MN)
  • Table 21 Global Peptide Synthesis Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 22 Global Peptide Synthesis Market Outlook, By Dermatology Disorders (2021-2030) ($MN)
  • Table 23 Global Peptide Synthesis Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 24 Global Peptide Synthesis Market Outlook, By CNS Disorders (2021-2030) ($MN)
  • Table 25 Global Peptide Synthesis Market Outlook, By Renal Disorders (2021-2030) ($MN)
  • Table 26 Global Peptide Synthesis Market Outlook, By Other Therapeutics (2021-2030) ($MN)
  • Table 27 Global Peptide Synthesis Market Outlook, By Diagnosis (2021-2030) ($MN)
  • Table 28 Global Peptide Synthesis Market Outlook, By Research (2021-2030) ($MN)
  • Table 29 Global Peptide Synthesis Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 30 Global Peptide Synthesis Market Outlook, By End User (2021-2030) ($MN)
  • Table 31 Global Peptide Synthesis Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 32 Global Peptide Synthesis Market Outlook, By Contract Manufacturing Organization (2021-2030) ($MN)
  • Table 33 Global Peptide Synthesis Market Outlook, By Academic (2021-2030) ($MN)
  • Table 34 Global Peptide Synthesis Market Outlook, By End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.